Journal of Clinical & Experimental Pharmacology

Editorial note on Clinical & Experimental Pharmacology

Dear Readers,

With a great pleasure, I would like to express my happiness on the eve of entering into the 10^th year of this Scientific Publishing Field. Initially we started this Journal of Clinical & Experimental Pharmacology with the aim to disseminate advanced knowledge all over the globe. Thankfully, with the constant support of Eminent Editorial Board Members, Potential Reviewers and Active Authors we are able to run this journal so successfully till now and we hope it continues in near future also. Journal of Clinical & Experimental Pharmacology provides the bimonthly publication of articles. In the year of 2019, we have published a very good number of articles, which were recent discoveries.

In the past years, apart from releasing regular issues at present, our main focus is to make scientific papers more accessible for aspiring researchers. With the support of Editorial board members, Executive editors and Guest Editors, we are planning to come up with interesting special issue topics to encourage the authors. Journal of Clinical & Experimental Pharmacology comes under the top ten journals in this open access field. In 2020, we have already released one issue and now we are in the process of releasing another issue.

As a Journal Manager, we will follow strictly scientific guidelines and Editor in Chief’s advice to retract or erratum of any article at any time if scientific misconduct or errors happened in any articles.

The journal serves as an international forum for sharing and exchange of research outcomes among academicians, scientists, researchers, health practitioners and students associated with experimental and clinical pharmacology and caters to their requirement of up-to-date and systematically generated knowledge which would aid them in designing new experiments. Our Journal will support authors by posting the published version of articles by NIH grant-holders and European or UK-based biomedical or life sciences grant-holders to PubMed Central immediately after publication. We promote our journal through different social media networks and digital marketing so that all the published articles which are published in journal reached the world and make your hard work popular.

I would to thank all our Editorial Board and Reviewers. A rapid review process is the main step in our process where reviewers play a major key role with appropriate expertise, or rejected without a formal review will be determined based on the quality. With your expertise and valuable decision giving us a percentage to reach quality. As per 2019 statistics 92% of submitted papers are accepted and published. I would like to thank reviewers for selecting quality work.

Finally, Journal of Clinical & Experimental Pharmacology sincerely appreciates each and every member for their valuable service in this Publication Process. We always look forward to work with many young scientists across the globe. We would like to thank authors for trusting us and supported for long 10 years with your effective research work. We are always here to help you and make you submission easy. Hope you will support and encourage us for upcoming years as well.

Richard Parker,

Feb 2020